S 331131
Alternative Names: S 33113; S 33113-1Latest Information Update: 09 Aug 2002
At a glance
- Originator Servier
- Class Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 17 Jan 2000 New profile
- 17 Jan 2000 Preclinical development for Neurological disorders (Prevention) in France (Unknown route)